Home › NCT06924944

Clinical Outcomes of Bilateral Clareon Vivity in Post-Refractive Patients

Who can join

All ages · All sexes

Inclusion Criteria:

* o Bilateral age-related visually significant cataracts in otherwise healthy eyes, undergoing uncomplicated bilateral sequential Clareon Vivity IOLs

  * Prior history of uncomplicated post-refractive myopic surgery (LASIK/PRK) with up to 1 enhancement treatment
  * Potential acuity measured post-operatively 20/25 or better in both eyes
  * Patients with regular astigmatism that can be managed with T3 toric lens or arcuate incision

Exclusion Criteria:

* o Ocular or systemic comorbidities that may alter or reduce visual acuity and contrast sensitivity such as severe dry eye/ocular surface disease, glaucoma, macular degeneration, retinopathy, neuro-ophthalmic diseases, etc.

  * Prior ocular surgeries other than uncomplicated corneal refractive surgery and excluding RK
  * Patients with irregular astigmatism/topography (to rule out signs of potential ectasia), corneal dystrophies, and pupil abnormalities
  * Total HOA cutoff of ≤0.5, coma ≤0.3
  * RLE patients

About the study

Millions of people have undergone laser vision correction surgery and are motivated to continue with spectacle independence as they develop presbyopia (gradual loss of your eyes' ability to focus on nearby objects)and cataract. However, having a history of refractive surgery, poses challenges in the selection of the IOLs and can lead to visual outcomes that are unpredictable. Data from an international registry and single prospective study show that Vivity IOL provided effective distance, intermediate and near vision in eyes with previous LASIK with minimal effects on day vision associated with the surgery. The purpose of this study is to evaluate the clinical outcomes of post-myopic refractive surgery patients implanted with the Clareon Vivity/Vivity Toric lenses

What is being tested

• cataract surgery (procedure)

Sponsor: Utah Eye Centers · Participants: 35 · Started: Jan 20, 2025

Contact the study team

• Rachel Buchanan · Phone: 8014099873

Official record on ClinicalTrials.gov — NCT06924944

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.